| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |